{"resourceType":"RegulatedAuthorization","id":"example","identifier":[{"system":"http://ema.europa.eu/example/marketingAuthorizationNumber","value":"EU/1/11/999/001"}],"region":[{"coding":[{"system":"http://ema.europa.eu/example/country","code":"EU"}]}],"status":{"coding":[{"system":"http://ema.europa.eu/example/authorizationstatus","code":"active"}]},"statusDate":"2015-01-14","validityPeriod":{"start":"2014-09-03","end":"2020-05-20"},"holder":{"reference":"Organization/example"},"regulator":{"reference":"Organization/example"},"case":{"identifier":{"system":"http://ema.europa.eu/example/procedureidentifier-number","value":"EMEA/H/C/009999/IA/0099/G"},"type":{"coding":[{"system":"http://ema.europa.eu/example/marketingAuthorizationProcedureType","code":"VariationTypeIA"}]},"datePeriod":{"start":"2014-09-02","end":"2015-08-21"},"application":[{"identifier":{"system":"http://ema.europa.eu/example/applicationidentifier-number","value":"IA38G"},"type":{"coding":[{"system":"http://ema.europa.eu/example/marketingAuthorizationApplicationType","code":"GroupTypeIAVariationNotification"}]},"dateDateTime":"2015-08-01"},{"identifier":{"system":"http://ema.europa.eu/example/applicationidentifier-number","value":"IA38F"},"type":{"coding":[{"system":"http://ema.europa.eu/example/marketingAuthorizationApplicationType","code":"GroupTypeIAVariationNotification"}]},"dateDateTime":"2014-09-01"}]}}
{"resourceType":"RegulatedAuthorization","id":"basic-drug-auth","subject":[{"reference":"MedicinalProductDefinition/equilidem"}],"type":{"text":"Regulatory Drug Marketing Approval"},"status":{"coding":[{"code":"active"}]},"statusDate":"2016-01-01","holder":{"reference":"Organization/EqlidrugCo","display":"EquiliDrugCo Holdings Inc."},"regulator":{"reference":"Organization/FDA","display":"FDA"}}